Dr. Julie E. Goodwin

Matthew Abramowitz, M.D., M.S. completed his medical education at the Albert Einstein College of Medicine and internal medicine residency at Montefiore Medical Center, where he was a Chief Resident. He remained at Einstein/Montefiore for nephrology fellowship and earned a Master’s in Clinical Research through Einstein’s Clinical Research Training Program. He is currently Professor of Medicine (Nephrology) at Einstein, Scientific Director of the Clinical Research Center and the Advanced Biomarker and Biorepository Core within the Einstein-Montefiore Institute for Clinical and Translational Research, and Scientific Director of the Cancer Biorepository Shared Resource within the Montefiore Einstein Cancer Center. Dr. Abramowitz is rated as a Distinguished provider by MediFind in the treatment of Metabolic Acidosis. His top areas of expertise are Metabolic Acidosis, Chronic Kidney Disease, Calcinosis, End-Stage Renal Disease (ESRD), and Kidney Transplant.

Sharad Sathyan is a Nephrologist in Bloomfield, Connecticut. Dr. Sathyan is rated as a Distinguished provider by MediFind in the treatment of Metabolic Acidosis. His top areas of expertise are Chronic Kidney Disease, Acute Kidney Failure, End-Stage Renal Disease (ESRD), and Lactic Acidosis.

Frederick J. Kaskel, MD, PhD, is involved in basic and clinical investigations into the mechanisms of the major kidney disorders in pediatrics. He is particularly interested in the physiology and pathophysiology of normal and abnormal development and function of the kidneys throughout the critical periods of growth and maturation extending into adolescence and young adulthood. He is actively involved in a clinical trial funded by the National Institutes of Health (NIH) to find the most efficacious therapy for focal segmental glomerulosclerosis, one of the major causes of progressive glomerular disease, while investigating the molecular etiologies for its expression. Another NIH-supported study involves chronic kidney disease in children and how it affects their growth and neurocognitive development, and the risk factors for cardiovascular disease and renal progression. Dr. Kaskel is rated as a Distinguished provider by MediFind in the treatment of Metabolic Acidosis. His top areas of expertise are Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease, Metabolic Acidosis, and Kidney Transplant.